{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:23:22Z","timestamp":1789986202609,"version":"4.0.1"},"reference-count":44,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is characterised by \u03b2-amyloid (A\u03b2) plaque accumulation and tau hyperphosphorylation. H3 relaxin, a neuro-peptide, is known to exert neuroprotective effects. In this study, we investigated how H3 relaxin confers neuroprotection in a streptozotocin (STZ)-induced mouse model and modulates PI3K\/Akt-mTOR signalling. Mice were divided into four groups (\n                    <jats:italic>n<\/jats:italic>\n                    = 6 per group): control (saline), STZ, STZ + H3 relaxin, and STZ + donepezil. Following STZ induction, H3 relaxin (1 \u00b5g per day) was administered intracerebro ventricularly (ICV) for 14 consecutive days, whereas donepezil (2.5 mg kg\n                    <jats:sup>\u20131<\/jats:sup>\n                    per day) was administered orally for the same duration. Cognitive performance was assessed using the Morris water maze (MWM) test. A\u03b2 deposition in the cortex was evaluated through immunohistochemistry. Western blotting was conducted for tau phospho rylation, PI3K\/Akt\/mTOR signalling, and autophagy markers in the hippocampus. Oxidative stress and inflammation markers were measured using ELISA. H3 relaxin markedly improved memory by decreasing escape latency and duration while spending more time in the target quadrant in the MWM test. Additionally, H3 relaxin reduced A\u03b2 plaque burden and tau phosphorylation (Ser396\/404) while enhancing PI3K\/Akt-mTOR signalling. Oxidative stress was attenuated, as evidenced by increased GSH and HO-1 levels and reduced MDA and H\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    concentrations. Moreover, markers of inflammation, NF-\u03baB and TNF-\u03b1 were suppressed. Overall, H3 relaxin ameliorated cognitive deficits in STZ-induced AD mice through modulation of impaired PI3K\/Akt-mTOR signalling, reduction of A\u03b2 and tau pathology, and promotion of autophagy.\n                  <\/jats:p>","DOI":"10.2478\/acph-2026-0009","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:59:50Z","timestamp":1774533590000},"page":"1-18","source":"Crossref","is-referenced-by-count":1,"title":["H3 relaxin mediated neuroprotection in Alzheimer\u2019s disease pathology induced by streptozotocin in mouse models: Impact on memory improvement, autophagy and PI3K\/Akt-mTOR signalling pathway"],"prefix":"10.2478","volume":"76","author":[{"given":"Huiyu","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurology Harbin 242 Hospital , Harbin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Regular Physical Examination Center , Shandong Public Health Clinical Center Shandong University , Jinan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaik Althaf","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Zoology, College of Science , King Saud University P.O. Box 2454 , Riyadh Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6189-6571","authenticated-orcid":false,"given":"Hua","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology Shaanxi Aerospace Hospital Xi\u2019an , , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2026051108174609731_j_acph-2026-0009_ref_001","doi-asserted-by":"crossref","unstructured":"P. T. Kamatham, R. Shukla, D. K. Khatri and L. K. Vora, Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier, Ageing Res. Rev. 101 (2024) Article ID 102481 (23 pages); https:\/\/doi.org\/10.1016\/j.arr.2024.102481","DOI":"10.1016\/j.arr.2024.102481"},{"key":"2026051108174609731_j_acph-2026-0009_ref_002","doi-asserted-by":"crossref","unstructured":"X. Xia, Q. Jiang, J. McDermott and J. J. Han, Aging and Alzheimer\u2019s disease: Comparison and associations from molecular to system level, Aging Cell 17(5) (2018) e12802 (14 pages); https:\/\/doi.org\/10.1111\/acel.12802","DOI":"10.1111\/acel.12802"},{"key":"#cr-split#-2026051108174609731_j_acph-2026-0009_ref_003.1","doi-asserted-by":"crossref","unstructured":"Alzheimer's Association, 2024 Alzheimer's disease facts and figures, Alzheimers Dement. 20(5) (2024) 3708-3821","DOI":"10.1002\/alz.13809"},{"key":"#cr-split#-2026051108174609731_j_acph-2026-0009_ref_003.2","unstructured":"Alzheimer's Association, 2024 Alzheimer's disease facts and figures, Alzheimers Dement. 20"},{"key":"#cr-split#-2026051108174609731_j_acph-2026-0009_ref_003.3","doi-asserted-by":"crossref","unstructured":"(5) (2024) 3708-3821; https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"2026051108174609731_j_acph-2026-0009_ref_004","doi-asserted-by":"crossref","unstructured":"A. A. Rostagno, Pathogenesis of Alzheimer\u2019s disease, Int. J. Mol. Sci. 24(1) (2023) Article ID 107 (4 pages); https:\/\/doi.org\/10.3390\/ijms24010107","DOI":"10.3390\/ijms24010107"},{"key":"2026051108174609731_j_acph-2026-0009_ref_005","doi-asserted-by":"crossref","unstructured":"S. Tiwari, V. Atluri, A. Kaushik, A. Yndart and M. Nair, Alzheimer\u2019s disease: Pathogenesis, diagnostics, and therapeutics, Int. J. Nanomed. 14 (2019) 5541\u20135554; https:\/\/doi.org\/10.2147\/IJN.S200490","DOI":"10.2147\/IJN.S200490"},{"key":"2026051108174609731_j_acph-2026-0009_ref_006","doi-asserted-by":"crossref","unstructured":"N. Guo, X. Wang, M. Xu, J. Bai, H. Yu and Z. Le, PI3K\/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression, Pharmacol. Res. 206 (2024) Article ID 107300 (12 pages); https:\/\/doi.org\/10.1016\/j.phrs.2024.107300","DOI":"10.1016\/j.phrs.2024.107300"},{"key":"2026051108174609731_j_acph-2026-0009_ref_007","doi-asserted-by":"crossref","unstructured":"J. Pan, Q. Yao, Y. Wang, S. Chang, C. Li, Y. Wu, J. Shen and R. Yang, The role of PI3K signaling pathway in Alzheimer\u2019s disease, Front. Aging Neurosci. 16 (2024) Article ID 1459025 (17 pages); https:\/\/doi.org\/10.3389\/fnagi.2024.1459025","DOI":"10.3389\/fnagi.2024.1459025"},{"key":"2026051108174609731_j_acph-2026-0009_ref_008","doi-asserted-by":"crossref","unstructured":"S. Davoody, A. Asgari Taei, P. Khodabakhsh and L. Dargahi, mTOR signaling and Alzheimer\u2019s disease: What we know and where we are?, CNS Neurosci. Ther. 30(4) (2024) e14463 (17 pages); https:\/\/doi.org\/10.1111\/cns.14463","DOI":"10.1111\/cns.14463"},{"key":"2026051108174609731_j_acph-2026-0009_ref_009","doi-asserted-by":"crossref","unstructured":"W. Li, P. He, Y. Huang, Y. F. Li, J. Lu, M. Li, H. Kurihara, Z. Luo, T. Meng, M. Onishi, C. Ma, L. Jiang, Y. Hu, Q. Gong, D. Zhu, Y. Xu, R. Liu, L. Liu, C. Yi, Y. Zhu, N. Ma, K. Okamoto, Z. Xie, J. Liu, R. R. He and D. Feng, Selective autophagy of intracellular organelles: Recent research advances, Theranostics 11(1) (2021) 222\u2013256; https:\/\/doi.org\/10.7150\/thno.49860","DOI":"10.7150\/thno.49860"},{"key":"2026051108174609731_j_acph-2026-0009_ref_010","doi-asserted-by":"crossref","unstructured":"Y. Zhao, Y. Zhang, J. Zhang, X. Zhang and G. Yang, Molecular mechanism of autophagy: Its role in the therapy of Alzheimer\u2019s disease, Curr. Neuropharmacol. 18(8) (2020) 720\u2013739; https:\/\/doi.org\/10.2174\/1570159X18666200114163636","DOI":"10.2174\/1570159X18666200114163636"},{"key":"2026051108174609731_j_acph-2026-0009_ref_011","doi-asserted-by":"crossref","unstructured":"M. Eshraghi, A. Adlimoghaddam, A. Mahmoodzadeh, F. Sharifzad, H. Yasavoli-Sharahi, S. Lorzadeh, B. C. Albensi and S. Ghavami, Alzheimer\u2019s disease pathogenesis: Role of autophagy and mitophagy focusing on microglia, Int. J. Mol. Sci. 22(7) (2021) Article ID 3330 (36 pages); https:\/\/doi.org\/10.3390\/ijms22073330","DOI":"10.3390\/ijms22073330"},{"key":"2026051108174609731_j_acph-2026-0009_ref_012","doi-asserted-by":"crossref","unstructured":"Z. Zhang, X. Yang, Y. Q. Song and J. Tu, Autophagy in Alzheimer\u2019s disease pathogenesis: Therapeutic potential and future perspectives, Ageing Res. Rev. 72 (2021) Article ID 101464 (15 pages); https:\/\/doi.org\/10.1016\/j.arr.2021.101464","DOI":"10.1016\/j.arr.2021.101464"},{"key":"2026051108174609731_j_acph-2026-0009_ref_013","doi-asserted-by":"crossref","unstructured":"N. Mizushima, Autophagic flux measurement: Cargo degradation versus generation of degradation products, Curr. Opin. Cell Biol. 93 (2025) Article ID 102463 (8 pages); https:\/\/doi.org\/10.1016\/j.ceb.2025.102463","DOI":"10.1016\/j.ceb.2025.102463"},{"key":"2026051108174609731_j_acph-2026-0009_ref_014","doi-asserted-by":"crossref","unstructured":"L. Gomez-Virgilio, M. D. Silva-Lucero, D. S. Flores-Morelos, J. Gallardo-Nieto, G. Lopez-Toledo, A. M. Abarca-Fernandez, A. E. Zacapala-Gomez, J. Luna-Munoz, F. Montiel-Sosa, L. O. Soto-Rojas, M. Pacheco-Herrero and M. D. Cardenas-Aguayo, Autophagy: A key regulator of homeostasis and disease \u2013 An overview of molecular mechanisms and modulators, Cells 11(15) (2022) Article ID 2262 (40 pages); https:\/\/doi.org\/10.3390\/cells11152262","DOI":"10.3390\/cells11152262"},{"key":"2026051108174609731_j_acph-2026-0009_ref_015","doi-asserted-by":"crossref","unstructured":"Z. Deng, Y. Dong, X. Zhou, J. H. Lu and Z. Yue, Pharmacological modulation of autophagy for Alzheimer\u2019s disease therapy: Opportunities and obstacles, Acta Pharm. Sin. B 12(4) (2022) 1688\u20131706; https:\/\/doi.org\/10.1016\/j.apsb.2021.12.009","DOI":"10.1016\/j.apsb.2021.12.009"},{"key":"2026051108174609731_j_acph-2026-0009_ref_016","doi-asserted-by":"crossref","unstructured":"H. Leysen, D. Walter, L. Clauwaert, L. Hellemans, J. van Gastel, L. Vasudevan, B. Martin and S. Maudsley, The relaxin-3 receptor RXFP3 is a modulator of aging-related disease, Int. J. Mol. Sci. 23(8) (2022) Article ID 4387 (22 pages); https:\/\/doi.org\/10.3390\/ijms23084387","DOI":"10.3390\/ijms23084387"},{"key":"2026051108174609731_j_acph-2026-0009_ref_017","doi-asserted-by":"crossref","unstructured":"S. Ma, C. M. Smith, A. Blasiak and A. L. Gundlach, Distribution, physiology and pharmacology of relaxin-3\/RXFP3 systems in brain, Br. J. Pharmacol. 174(10) (2017) 1034\u20131048; https:\/\/doi.org\/10.1111\/bph.13659","DOI":"10.1111\/bph.13659"},{"key":"2026051108174609731_j_acph-2026-0009_ref_018","doi-asserted-by":"crossref","unstructured":"D. J. Scott, K. J. Rosengren and R. A. Bathgate, The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2, Mol. Endocrinol. 26(11) (2012) 1896\u20131906; https:\/\/doi.org\/10.1210\/me.2012-1188","DOI":"10.1210\/me.2012-1188"},{"key":"2026051108174609731_j_acph-2026-0009_ref_019","doi-asserted-by":"crossref","unstructured":"J. R. Kumar, R. Rajkumar, T. Jayakody, S. Marwari, J. M. Hong, S. Ma, A. L. Gundlach, M. K. P. Lai and G. S. Dawe, Relaxin\u2019 the brain: Targeting the nucleus incertus network and relaxin-3\/RXFP3 system in neuropsychiatric disorders, Br. J. Pharmacol. 174(10) (2016) 1061\u20131076; https:\/\/doi.org\/10.1111\/bph.13564","DOI":"10.1111\/bph.13564"},{"key":"2026051108174609731_j_acph-2026-0009_ref_020","doi-asserted-by":"crossref","unstructured":"M. E. S. Sorial, R. M. Abdelghany and N. El Sayed, Modulation of the cognitive impairment associated with Alzheimer\u2019s disease by valproic acid: Possible drug repurposing, Inflammopharmacology 33(4) (2025) 2083\u20132094; https:\/\/doi.org\/10.1007\/s10787-025-01695-0","DOI":"10.1007\/s10787-025-01695-0"},{"key":"2026051108174609731_j_acph-2026-0009_ref_021","unstructured":"M. Levin-Arama, L. Abraham, T. Waner, A. Harmelin, D. M. Steinberg, T. Lahav and M. Harlev, Subcutaneous compared with intraperitoneal ketamine-xylazine for anesthesia of mice, J. Am. Assoc. Lab. Anim. Sci. 55(6) (2016) 794\u2013800."},{"key":"2026051108174609731_j_acph-2026-0009_ref_022","doi-asserted-by":"crossref","unstructured":"D. Kaur, A. K. Grewal, S. H. Almasoudi, A. H. Almehmadi, B. A. Alsfouk, A. Kumar, V. Singh, A. Alexiou, M. Papadakis, N. N. Welson, T. G. Singh and G. E.-S. Batiha, Neuroprotective effect of tozasertib in streptozotocin-induced Alzheimer\u2019s mice model, Sci. Rep. 15 (2025) Article ID 28963 (16 pages); https:\/\/doi.org\/10.1038\/s41598-025-13920-5","DOI":"10.1038\/s41598-025-13920-5"},{"key":"2026051108174609731_j_acph-2026-0009_ref_023","doi-asserted-by":"crossref","unstructured":"G. M. Shankar, M. A. Leissring, A. Adame, X. Sun, E. Spooner, E. Masliah, D. J. Selkoe, C. A. Le-mere and D. M. Walsh, Biochemical and immunohistochemical analysis of an Alzheimer\u2019s disease mouse model reveals multiple cerebral amyloid-\u03b2 assembly forms, Neurobiol. Dis. 36(2) (2009) 293\u2013302; https:\/\/10.1016\/j.nbd.2009.07.021","DOI":"10.1016\/j.nbd.2009.07.021"},{"key":"2026051108174609731_j_acph-2026-0009_ref_024","doi-asserted-by":"crossref","unstructured":"L. J. Lissner, K. M. Wartchow, A. P. Toniazzo, C. A. Goncalves and L. Rodrigues, Object recognition and Morris water maze to detect cognitive impairment from mild hippocampal damage in rats, Pharmacol. Biochem. Behav. 210 (2021) Article ID 173273 (9 pages); https:\/\/doi.org\/10.1016\/j.pbb.2021.173273","DOI":"10.1016\/j.pbb.2021.173273"},{"key":"2026051108174609731_j_acph-2026-0009_ref_025","doi-asserted-by":"crossref","unstructured":"A. Vogel-Ciernia and M. A. Wood, Examining object location and object recognition memory in mice, Curr. Protoc. Neurosci. 69 (2014) 8.31.1-8.31.17; https:\/\/doi.org\/10.1002\/0471142301.ns0831s69","DOI":"10.1002\/0471142301.ns0831s69"},{"key":"2026051108174609731_j_acph-2026-0009_ref_026","doi-asserted-by":"crossref","unstructured":"R. Rajmohan and P. H. Reddy, Amyloid-\u03b2 and phosphorylated tau accumulations cause synaptic abnormalities in Alzheimer\u2019s disease neurons, J. Alzheimer\u2019s Dis. 57(4) (2017) 975\u2013999; https:\/\/doi.org\/10.3233\/JAD-160612","DOI":"10.3233\/JAD-160612"},{"key":"2026051108174609731_j_acph-2026-0009_ref_027","doi-asserted-by":"crossref","unstructured":"H. Dong, C. M. Yuede, C. A. Coughlan, K. M. Murphy and J. G. Csernansky, Effects of donepezil on amyloid-\u03b2 and synapse density in the Tg2576 mouse model of Alzheimer\u2019s disease, Brain Res. 1303 (2009) 169\u2013178; https:\/\/doi.org\/10.1016\/j.brainres.2009.09.097","DOI":"10.1016\/j.brainres.2009.09.097"},{"key":"#cr-split#-2026051108174609731_j_acph-2026-0009_ref_028.1","doi-asserted-by":"crossref","unstructured":"K. Dasuri, L. Zhang, S. O. Kim, A. J. Bruce-Keller and J. N. Keller, Dietary and donepezil modulation of mammalian target of rapamycin signaling and neuroinflammation in the brain, Biochim. Biophys. Acta Mol. Basis Dis. 1862(2) (2016) 274-283","DOI":"10.1016\/j.bbadis.2015.11.002"},{"key":"#cr-split#-2026051108174609731_j_acph-2026-0009_ref_028.2","doi-asserted-by":"crossref","unstructured":"K. Dasuri, L. Zhang, S. O. Kim, A. J. Bruce-Keller and J. N. Keller, Dietary and donepezil modulation of mammalian target of rapamycin signaling and neuroinflammation in the brain, Biochim. Biophys. Acta Mol. Basis Dis. 1862","DOI":"10.1016\/j.bbadis.2015.11.002"},{"key":"#cr-split#-2026051108174609731_j_acph-2026-0009_ref_028.3","doi-asserted-by":"crossref","unstructured":"(2) (2016) 274-283; https:\/\/doi.org\/10.1016\/j.bbadis.2015.11.002","DOI":"10.1016\/j.bbadis.2015.11.002"},{"key":"2026051108174609731_j_acph-2026-0009_ref_029","doi-asserted-by":"crossref","unstructured":"S. Bathina and U. N. Das, Dysregulation of the PI3K-Akt-mTOR pathway in the brain of streptozotocin-induced type 2 diabetic rats, Lipids Health Dis. 17 (2018) Article ID 168 (11 pages); https:\/\/doi.org\/10.1186\/s12944-018-0809-2","DOI":"10.1186\/s12944-018-0809-2"},{"key":"2026051108174609731_j_acph-2026-0009_ref_030","doi-asserted-by":"crossref","unstructured":"Y. Fu, J. Zhang, R. Qin, Y. Ren, T. Zhou, B. Han and B. Liu, Activating autophagy to eliminate toxic protein aggregates in neurodegenerative diseases, Pharmacol. Rev. 77(3) (2025) Article ID 100053 (50 pages); https:\/\/doi.org\/10.1016\/j.pharmr.2025.100053","DOI":"10.1016\/j.pharmr.2025.100053"},{"key":"2026051108174609731_j_acph-2026-0009_ref_031","doi-asserted-by":"crossref","unstructured":"Q. Wang, Y. Wang, S. Li and J. Shi, PACAP-sirtuin-3 alleviates cognitive impairment through autophagy in Alzheimer\u2019s disease, Alzheimers Res. Ther. 15(1) (2023) Article ID 184 (20 pages); https:\/\/doi.org\/10.1186\/s13195-023-01334-2","DOI":"10.1186\/s13195-023-01334-2"},{"key":"2026051108174609731_j_acph-2026-0009_ref_032","doi-asserted-by":"crossref","unstructured":"S. Guo, L. Yi, M. Luo, Z. Dong and Y. Du, Parishin A ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer\u2019s disease, Front. Aging Neurosci. 17 (2025) Article ID 1516190 (16 pages); https:\/\/doi.org\/10.3389\/fnagi.2025.1516190","DOI":"10.3389\/fnagi.2025.1516190"},{"key":"2026051108174609731_j_acph-2026-0009_ref_033","doi-asserted-by":"crossref","unstructured":"F. Islam, M. H. Nafady, M. R. Islam, S. Saha, S. Rashid, S. Akter, M. H. Or-Rashid, M. F. Akhtar, A. Perveen, G. M. Ashraf, H. M. Rahman and S. H. Sweilam, Resveratrol and neuroprotection against Alzheimer\u2019s disease, Mol. Neurobiol. 59(7) (2022) 4384\u20134404; https:\/\/doi.org\/10.1007\/s12035-022-02859-7","DOI":"10.1007\/s12035-022-02859-7"},{"key":"2026051108174609731_j_acph-2026-0009_ref_034","doi-asserted-by":"crossref","unstructured":"Y. Chen and Y. Yu, Tau and neuroinflammation in Alzheimer\u2019s disease: Interplay mechanisms and clinical translation, J. Neuroinflammation 20(1) (2023) Article ID 165 (21 pages); https:\/\/doi.org\/10.1186\/s12974-023-02853-3","DOI":"10.1186\/s12974-023-02853-3"},{"key":"2026051108174609731_j_acph-2026-0009_ref_035","doi-asserted-by":"crossref","unstructured":"P. J. Ryan, E. Buchler, F. Shabanpoor, M. A. Hossain, J. D. Wade, A. J. Lawrence and A. L. Gundlach, Central RXFP3 activation decreases anxiety- and depressive-like behaviours in rats, Behav. Brain Res. 244 (2013) 142\u2013151; https:\/\/doi.org\/10.1016\/j.bbr.2013.01.034","DOI":"10.1016\/j.bbr.2013.01.034"},{"key":"2026051108174609731_j_acph-2026-0009_ref_036","doi-asserted-by":"crossref","unstructured":"S. W. Jere, N. N. Houreld and H. Abrahamse, Role of PI3K\/AKT (mTOR and GSK-3\u03b2) signaling in diabetic wound healing, Cytokine Growth Factor Rev. 50 (2019) 52\u201359; https:\/\/doi.org\/10.1016\/j.cytogfr.2019.03.001","DOI":"10.1016\/j.cytogfr.2019.03.001"},{"key":"2026051108174609731_j_acph-2026-0009_ref_037","doi-asserted-by":"crossref","unstructured":"C. Z. Yang, S. H. Wang, R. H. Zhang, J. H. Lin, Y. H. Tian, Y. Q. Yang, J. Liu and Y. X. Ma, Neuro-protective effect of astragalin via activating PI3K\/Akt-mTOR-mediated autophagy on APP\/PS1 mice, Cell Death Discov. 9 (2023) Article ID 15 (13 pages); https:\/\/doi.org\/10.1038\/s41420-023-01324-1","DOI":"10.1038\/s41420-023-01324-1"},{"key":"2026051108174609731_j_acph-2026-0009_ref_038","doi-asserted-by":"crossref","unstructured":"S. A. El-Maraghy, A. Reda, R. M. Essam and M. A. Kortam, The citrus flavonoid \u201cNobiletin\u201d impedes STZ-induced Alzheimer\u2019s disease in a mouse model through regulating autophagy mastered by SIRT1\/FoxO3a mechanism, Inflammopharmacology 31(5) (2023) 2701\u20132717; https:\/\/doi.org\/10.1007\/s10787-023-01292-z","DOI":"10.1007\/s10787-023-01292-z"},{"key":"2026051108174609731_j_acph-2026-0009_ref_039","doi-asserted-by":"crossref","unstructured":"Q. Qiu, X. Lei, Y. Wang, H. Xiong, Y. Xu, H. Sun, H. Xu and N. Zhang, Naringin protects against tau hyperphosphorylation via ER, PI3K\/Akt and GSK-3\u03b2 signaling, Behav. Neurol. 2023 (2023) Article ID 1857330 (16 pages); https:\/\/doi.org\/10.1155\/2023\/1857330","DOI":"10.1155\/2023\/1857330"},{"key":"2026051108174609731_j_acph-2026-0009_ref_040","doi-asserted-by":"crossref","unstructured":"M. A. Salem, B. Budzynska, J. Kowalczyk, N. S. El Sayed and S. M. Mansour, Tadalafil and bergapten mitigate STZ-induced sporadic Alzheimer\u2019s disease via PI3K\/Akt, Wnt\/\u03b2-catenin and AMPK\/mTOR pathways, Toxicol. Appl. Pharmacol. 429 (2021) Article ID 115697 (14 pages); https:\/\/doi.org\/10.1016\/j.taap.2021.115697","DOI":"10.1016\/j.taap.2021.115697"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2026-0009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:24:06Z","timestamp":1778487846000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2026-0009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.2478\/acph-2026-0009"],"URL":"https:\/\/doi.org\/10.2478\/acph-2026-0009","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}